News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catalyst Pharmaceutical Partners, Inc. (CPRX) to Present at Rodman & Renshaw's 15th Annual Global Investment Conference


9/3/2013 9:42:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CORAL GABLES, Fla., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer, will be presenting at Rodman & Renshaw's 15th Annual Global Investment Conference, which is being held on September 8-10, 2013 at The Millennium Broadway Hotel in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES